Changing to Avastin could save NHS £100m a year - Cameron Optometry | Cameron Optometry
Changing to Avastin could save NHS £100m a year

Changing to Avastin could save NHS £100m a year

Posted on 25th November 2014

The drug Avastin has been in the newscalling for its use in the UK in a bid to save millions each year.

eye-care

Popular in the US, Avastin is used for patients with age-related macular degeneration (AMD). It has been on the market for years, gone through all the testing and has been proven to be as effective as Lucentis, the NHS approved drug for the same condition. The difference is cost. Lucentis typically costs around £700 per treatment, compared to Avastin which is about £70. Yet red tape seems to be halting its use.

It is currently unlicensed in the UK so should anything go wrong with its use, the practitioner may not be legally covered. However, in times of austerity and it is perhaps time for the NHS to move forward and license its use.


Related Posts

Coronavirus, COVID-19, advice

24th March 2020

In response to the outbreak of the coronavirus, COVID-19, we are advising all patients to follow the latest Government advice, NHS advice and guidance from Health Protection Scotland. This page wil...

Read more

Colour analysis at Cameron Optometry

02nd March 2020

Colour can have a way of transforming how we look and feel. We love colour at the Frame Room. We regularly encourage our patients to jump out of their comfort zones and embrace brightly coloured eyewe...

Read more

Cameron Optometry becomes only Scottish practice with five independent prescribing optometrists 

27th February 2020

Cameron Optometry’s longest-serving optometrist, Heather Grandon, has completed her Independent Prescribing qualification with an impressive 95% in her final exam. Heather joins our other four optom...

Read more

Celebrating 50 years in practice

21st February 2020

This year we reach a new milestone; Cameron Optometry is 50. We are looking forward to a year of celebrations, as we reflect on this past half century, as well as looking towards the next 50 years in ...

Read more